Home A very rare cause of arthrogryposis multiplex congenita: a novel mutation in TOR1A
Article
Licensed
Unlicensed Requires Authentication

A very rare cause of arthrogryposis multiplex congenita: a novel mutation in TOR1A

  • Emre Sarıkaya ORCID logo EMAIL logo , Fırat Özçelik , Ülkü Gül Şiraz , Nihal Hatipoglu , Tamer Güneş and Munis Dündar
Published/Copyright: March 16, 2022

Abstract

Objectives

Arthrogryposis multiplex congenita-5 (AMC5) is an autosomal recessive disease caused by homozygous or compound heterozygous mutations in the TOR1A gene on chromosome 9q34. Congenital multiple joint contractures with microcephaly, typical facial dysmorphism, developmental delay, strabismus, tremor, and increased tone are the main characteristics defined in seven patients thus far. One third of the individuals with monoallelic mutations of the gene develop isolated early-onset dystonia (DYT1 dystonia), which is inherited in an autosomal dominant fashion, with variable expressivity and incomplete penetrance. We believe that different inheritance patterns of the same gene resulting in different phenotypes will provide an opportunity to understand other similar disease groups and different aspects of gene functions.

Case presentation

We present a case with severe arthrogryposis multiplex congenita, respiratory failure, and feeding difficulties, with additional hitherto unreported symptoms, such as spontaneous bone fracture, sliding esophageal hernia, and uterine prolapse. The patient carried a novel homozygous variant (c.835delA, p.Lys275Asnfs*3) in the TOR1A gene (NM_000113.2).

Conclusions

We want to contribute to the phenotypic and genotypic spectra of this extremely rare disease.


Corresponding author: Emre Sarıkaya, MD, Department of Pediatric Endocrinology, School of Medicine, Erciyes University, Köşk Mahallesi, Prof. Dr. Turhan Feyzioğlu Caddesi No: 42, Melikgazi, 38039, Kayseri, Turkey, Phone: +90 530 783 41 45, +90 352 207 66 66 -Ext. 25280, Fax: +90 352 437 58 25, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Lowry, RB, Sibbald, B, Bedard, T, Hall, JG. Prevalence of multiple congenital contractures including arthrogryposis multiplex congenita in Alberta, Canada, and a strategy for classification and coding. Birth Defects Res A Clin Mol Teratol 2010;88:1057–61. https://doi.org/10.1002/bdra.20738.Search in Google Scholar PubMed

2. Laquerriere, A, Jaber, D, Abiusi, E, Maluenda, J, Mejlachowicz, D, Vivanti, A, et al.. Phenotypic spectrum and genomics of undiagnosed arthrogryposis multiplex congenita. J Med Genet 2021. https://doi.org/10.1136/jmedgenet-2020-107595.Search in Google Scholar PubMed

3. Hall, JG. Arthrogryposis (multiple congenital contractures): diagnostic approach to etiology, classification, genetics, and general principles. Eur J Med Genet 2014;57:464–72. https://doi.org/10.1016/j.ejmg.2014.03.008.Search in Google Scholar PubMed

4. Kiefer, J, Hall, JG. Gene ontology analysis of arthrogryposis (multiple congenital contractures). Am J Med Genet C Semin Med Genet 2019;181:310–26. https://doi.org/10.1002/ajmg.c.31733.Search in Google Scholar PubMed

5. Clark, R, Gold, J, Camacho, J, editors. Arthrogryposis associated with a homozygous frameshift variant in TOR1A: fetal-onset dystonia may cause severe congenital joint contractures. Vancouver, British Columbia, Canada: Annual Meeting of the American Society of Human Genetics; 2016.Search in Google Scholar

6. Kariminejad, A, Dahl-Halvarsson, M, Ravenscroft, G, Afroozan, F, Keshavarz, E, Goullee, H, et al.. TOR1A variants cause a severe arthrogryposis with developmental delay, strabismus and tremor. Brain 2017;140:2851–9. https://doi.org/10.1093/brain/awx230.Search in Google Scholar PubMed

7. Ozelius, LJ, Hewett, JW, Page, CE, Bressman, SB, Kramer, PL, Shalish, C, et al.. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40–8. https://doi.org/10.1038/ng0997-40.Search in Google Scholar PubMed

8. Isik, E, Aykut, A, Atik, T, Cogulu, O, Ozkinay, F. Biallelic TOR1A mutations cause severe arthrogryposis: a case requiring reverse phenotyping. Eur J Med Genet 2019;62:103544. https://doi.org/10.1016/j.ejmg.2018.09.011.Search in Google Scholar PubMed

9. Reichert, SC, Gonzalez-Alegre, P, Scharer, GH. Biallelic TOR1A variants in an infant with severe arthrogryposis. Neurol Genet 2017;3:e154. https://doi.org/10.1212/nxg.0000000000000154.Search in Google Scholar PubMed PubMed Central

10. Torres, GE, Sweeney, AL, Beaulieu, JM, Shashidharan, P, Caron, MG. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci USA 2004;101:15650–5. https://doi.org/10.1073/pnas.0308088101.Search in Google Scholar PubMed PubMed Central

11. Goodchild, RE, Kim, CE, Dauer, WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005;48:923–32. https://doi.org/10.1016/j.neuron.2005.11.010.Search in Google Scholar PubMed

Received: 2021-12-22
Accepted: 2022-02-19
Published Online: 2022-03-16
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Articles
  3. The genetic elucidation of monogenic obesity in the Arab world: a systematic review
  4. Global perspective on pediatric growth hormone registries: a systematic review
  5. Mini Review
  6. Considering metformin as a second-line treatment for children and adolescents with prediabetes
  7. Original Articles
  8. Central adrenal insufficiency screening with morning plasma cortisol and ACTH levels in Prader–Willi syndrome
  9. Clinical characteristics and genetics analysis for the ITD of congenital hypothyroidism
  10. Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis
  11. The role of circulating miRNAs in leptin resistance in obese children
  12. Relationship between height age, bone age and chronological age in normal children in the context of nutritional and pubertal status
  13. Clinical, biochemical, and biomolecular aspects of congenital adrenal hyperplasia in a group of Cameroonian children and adolescents
  14. Ten year analysis of the clinic profile of the tertiary paediatric endocrine service in Western Australia
  15. Postoperative intensive care management and residual endocrinopathy of pediatric supratentorial brain tumors: a retrospective cohort study
  16. Successful telehealth transformation of a pediatric outpatient obesity teaching program due to the COVID-19 pandemic – the “Video KiCK” program
  17. Glycemic control among children with type 1 diabetes mellitus and its determinants in a resource-limited setting
  18. Letter to the Editor
  19. Anxiety, pediatric type 1 diabetes and COVID-19 lockdown
  20. Short Communication
  21. Ethnic diversity and burden of polycystic ovary syndrome among US adolescent females
  22. Case Reports
  23. Feminizing adrenocortical oncocytoma presenting as precocious puberty: a case report and literature review
  24. Novel OTX2 loss of function variant associated with congenital hypopituitarism without eye abnormalities
  25. Bilateral Wilms’ tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region
  26. A very rare cause of arthrogryposis multiplex congenita: a novel mutation in TOR1A
Downloaded on 5.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0766/html
Scroll to top button